Pages that link to "Q72192627"

The following pages link to The synthesis of N-hydroxy-N'-phenyloctanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells (Q72192627):

Displaying 13 items.

• Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling (Q28473090) (← links)
• A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests (Q28535325) (← links)
• Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats (Q33772867) (← links)
• A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases (Q33999312) (← links)
• Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates (Q36372894) (← links)
• Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. (Q37550149) (← links)
• Synergistic induction of apoptosis in brain cancer cells by targeted codelivery of siRNA and anticancer drugs. (Q38610488) (← links)
• The effect of various zinc binding groups on inhibition of histone deacetylases 1-11. (Q39283136) (← links)
• Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expression (Q44366699) (← links)
• Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition (Q48114949) (← links)
• Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion. (Q52631118) (← links)
• Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET. (Q53010775) (← links)
• Silyl-mediated photoredox-catalyzed Giese reaction: addition of non-activated alkyl bromides (Q57496202) (← links)